Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin versus gabapentin versus placebo for post-endodontic pain in mandibular molars with irreversible pulpitis
IRCT20260826070808N1Phase 3Recruiting
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in irreversible pulpitis comparing Gabapentin pretreatment, Pregabalin pretreatment and Placebo pretreatment (3 arms). Primary endpoint: Pain intensity. Started Sep 2026; status: recruiting.
02
Drugs
pregabalingabapentin
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20260826070808N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260826070808N1.